Journal of Biological Engineering · Aug 11, 2026
PPARα mediates hypoxia-induced metabolic reprogramming to confer a redox-balanced synthetic phenotype in hiPSC-VSMCs for cell sheet-based vascular grafts
By Fang L, Sun X, Shu L et al.
BACKGROUND: Functional small-diameter tissue-engineered vascular grafts (TEVGs) require seed cells with robust proliferation and extracellular matrix (ECM) synthetic capacity. Human induced pluripotent stem cell-derived vascular smooth muscle cells (hiPSC-VSMCs) are promising but often functionally immature. While physiological hypoxia is a key developmental signal, its effects on hiPSC-VSMC phenotype, metabolism, and redox homeostasis remain unclear, and whether hypoxia-preconditioned cells can facilitate scaffold-free TEVG fabrication is unexplored. METHODS: HiPSCs were differentiated into VSMCs under normoxic or hypoxic conditions. Integrated transcriptomic, metabolomic, and functional assays were employed to evaluate phenotypic, metabolic, and redox changes. Peroxisome proliferator-activated receptor alpha (PPARα) was identified as a potential central hub by bioinformatics and its activity was modulated using agonist (WY14643) and antagonist (GW6471). A cell sheet (CS) platform was established and optimized by screening medium additives and seeding density. Optimized CSs were then rolled and matured within a bioreactor to generate scaffold-free TEVGs, followed by decellularization to produce ECM scaffolds evaluated for decellularization efficiency and ECM integrity. RESULTS: Physiological hypoxia (5% O₂) promoted hiPSC-VSMC proliferation and synthetic switching, with multi-omics revealing lipid downregulation and suggesting fatty acid β-oxidation activation. Hypoxia reduced oxidative stress, enhanced antioxidant defenses, and improved mitochondrial function, with PPARα emerging as a key mediator. Using optimized conditions (ITS + Ultroser™ G; 3.0 × 10⁵ cells/cm²), we generated robust CSs, which were rolled into scaffold-free TEVGs and decellularized to yield ECM scaffolds with DNA < 50 ng/mg and preserved ECM composition, meeting decellularization standards. CONCLUSION: Physiological hypoxia (5% O₂) activates PPARα, accompaning with enhanced hiPSC-VSMC proliferation, ECM synthesis, and redox homeostasis. Leveraging this insight, we established a simple, chemically defined strategy for CS fabrication and subsequent assembly of intact, decellularizable scaffold-free TEVG, providing a mechanistically validated proof-of-concept platform for future studies on scaffold-free vascular graft engineering.
doi.org/10.1186/s13036-026-00753-7Open accessPubMed 43040421Interventions